S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CLRB Cellectar Biosciences Inc

0.2535

-0.0222 (-8.05%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form 8-K - Current report

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Cellectar Biosciences Charts.

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Cellectar Biosciences Charts.

Cellectar Biosciences Inc News

Form 8-K - Current report
Wednesday 11 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring
Tuesday 10 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 18 November 2024 (1 month ago) • Edgar (US Regulatory)

Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
Monday 18 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 18 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
Thursday 14 November 2024 (1 month ago) • GlobeNewswire Inc.

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024
Monday 11 November 2024 (1 month ago) • GlobeNewswire Inc.

Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

More Cellectar Biosciences Inc News Articles

Enanta Pharmaceuticals

ELine Entertainment (CE)

Hallmark Venture (PK)

Asia Broadband (PK)

Virexit Technologies (PK)

KULR Technology

Intergrated Cannabis Sol... (PK)

Anavex Life Sciences

Impact Fusion (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions